A 59-year-old woman attends for her first NHS breast screening mammogram. She had breast augmentation with silicone implants 15 years ago following mastectomy for benign phyllodes tumour. She is asymptomatic. The screening unit contacts you to say that adequate breast tissue imaging was difficult to obtain due to the implants. What is the most appropriate management?
Q92
A 48-year-old man attends for an NHS Health Check. He drinks 6 pints of lager (4.5% ABV) on Friday and Saturday evenings, and 2-3 pints on Wednesday evenings. He scores 12 on the AUDIT (Alcohol Use Disorders Identification Test) questionnaire. He works full-time and reports no social or occupational problems related to alcohol. Liver function tests and gamma-GT are within normal limits. What is the most appropriate intervention at this consultation?
Q93
A 45-year-old woman with a BMI of 42 kg/m² attends for weight management. She has tried multiple commercial diet programmes without sustained success. Her blood pressure is 146/92 mmHg, HbA1c 43 mmol/mol, and she has grade 2 non-alcoholic fatty liver disease on ultrasound. She is motivated to lose weight and asks about pharmacological options. According to NICE guidance, which medication would be the most appropriate first-line pharmacological intervention?
Q94
A 28-year-old woman who is 28 weeks pregnant attends for routine antenatal care. Her midwife has documented that her oral glucose tolerance test (OGTT) shows a fasting glucose of 5.8 mmol/L and 2-hour glucose of 8.2 mmol/L. She has a BMI of 34 kg/m², and her father has type 2 diabetes. She feels well with no polyuria or polydipsia. What is the most appropriate immediate management of these results?
Q95
A 67-year-old woman attends following her NHS abdominal aortic aneurysm (AAA) screening ultrasound which detected a 4.8 cm infrarenal AAA. She is asymptomatic. She has well-controlled hypertension on ramipril 10mg daily, blood pressure 128/76 mmHg. She stopped smoking 5 years ago (30 pack-year history). She asks about her prognosis and management options. What is the most appropriate management plan?
Q96
A 66-year-old man attends for cardiovascular risk assessment. He has a 10-year QRISK3 score of 12%. He smokes 15 cigarettes daily, has a BMI of 31 kg/m², blood pressure 138/86 mmHg, total cholesterol 5.8 mmol/L, HDL 1.1 mmol/L, and HbA1c 41 mmol/mol. He is reluctant to take medication. Using motivational interviewing techniques, which approach is most likely to effectively support behaviour change?
Q97
A 30-year-old woman attends for cervical screening. Her hrHPV test is positive, and cytology shows low-grade dyskaryosis. Colposcopy performed 8 weeks later shows acetowhite changes in the transformation zone, and punch biopsies confirm CIN1. She has no symptoms and examination is otherwise normal. She is in a stable relationship and uses the combined oral contraceptive pill. What is the most appropriate management plan?
Q98
A 63-year-old man attends for discussion of his NHS bowel cancer screening result. His faecal immunochemical test (FIT) shows a result of 85 micrograms of haemoglobin per gram of faeces. He is asymptomatic with no change in bowel habit, no rectal bleeding, and no weight loss. Abdominal examination is unremarkable. He takes aspirin 75mg daily for secondary prevention following a previous myocardial infarction. What is the most appropriate management?
Q99
A 51-year-old woman with type 2 diabetes attends for her annual diabetic retinopathy screening. The report indicates 'R2 - referable retinopathy with venous beading and multiple deep retinal haemorrhages in all four quadrants, but no neovascularisation'. Visual acuity is 6/9 in both eyes. She reports no visual symptoms. Her HbA1c is 76 mmol/mol and blood pressure is 142/88 mmHg. What is the most appropriate action regarding her retinopathy?
Q100
A 64-year-old woman attends for results of her NHS breast screening mammogram. The report states 'M3 - indeterminate/probably benign calcifications detected in the upper outer quadrant of the right breast'. She is asymptomatic and has no palpable abnormality on clinical examination. Her mother had breast cancer diagnosed at age 72. What is the most appropriate next step in her management?
Screening & Prevention UK Medical PG Practice Questions and MCQs
Question 91: A 59-year-old woman attends for her first NHS breast screening mammogram. She had breast augmentation with silicone implants 15 years ago following mastectomy for benign phyllodes tumour. She is asymptomatic. The screening unit contacts you to say that adequate breast tissue imaging was difficult to obtain due to the implants. What is the most appropriate management?
A. Reassure her that breast screening is not necessary given her benign breast disease history
B. Advise her that mammographic screening is not suitable and she should perform monthly breast self-examination instead
C. Explain that she should have ultrasound screening instead of mammography every 3 years
D. Arrange for her to be recalled to the screening unit for additional imaging techniques including implant displacement views (Correct Answer)
E. Refer her to breast surgery for annual clinical examination as an alternative to mammographic screening
Explanation: ***Arrange for her to be recalled to the screening unit for additional imaging techniques including implant displacement views***- Women with **breast implants** are still eligible for screening; however, implants can obscure tissue, requiring specialized **Eklund (implant displacement) views**.- This technique involves pushing the implant back against the **chest wall** while pulling the breast tissue forward to ensure adequate visualization of the parenchyma.*Reassure her that breast screening is not necessary given her benign breast disease history*- A history of **benign phyllodes tumour** does not eliminate the risk of developing breast cancer in any remaining or contralateral breast tissue.- All women aged **50 to 71** (in the UK) are invited for screening regardless of previous benign diagnoses.*Advise her that mammographic screening is not suitable and she should perform monthly breast self-examination instead*- Mammography remains the **gold standard** for screening even with implants, provided that modified techniques are employed.- **Breast self-examination** alone is not a sufficient substitute for radiological screening and does not reduce breast cancer mortality.*Explain that she should have ultrasound screening instead of mammography every 3 years*- **Ultrasound** is typically used for targeted assessment of symptomatic masses or implant integrity, not as a primary population-based **screening tool**.- Routine screening protocol dictates that specialized mammographic views must be attempted first before considering alternative modalities.*Refer her to breast surgery for annual clinical examination as an alternative to mammographic screening*- **Annual clinical examination** is not a standard replacement for the high-sensitivity detection provided by mammographic imaging.- Screening units have specific internal protocols for **inadequate images**, and the correct pathway is a recall for technical repeats or additional views, not a surgical referral.
Question 92: A 48-year-old man attends for an NHS Health Check. He drinks 6 pints of lager (4.5% ABV) on Friday and Saturday evenings, and 2-3 pints on Wednesday evenings. He scores 12 on the AUDIT (Alcohol Use Disorders Identification Test) questionnaire. He works full-time and reports no social or occupational problems related to alcohol. Liver function tests and gamma-GT are within normal limits. What is the most appropriate intervention at this consultation?
A. Provide simple brief advice about reducing alcohol consumption to lower-risk levels
B. Refer to community alcohol services for specialist assessment and intervention
C. Arrange extended brief intervention focusing on behaviour change techniques over multiple sessions (Correct Answer)
D. Reassure that his drinking is not problematic given normal liver function tests
E. Prescribe thiamine supplementation and arrange follow-up in 2 weeks
Explanation: ***Arrange extended brief intervention focusing on behaviour change techniques over multiple sessions***
- An **AUDIT score of 8-15** indicates **hazardous drinking** (increasing risk), for which NICE guidelines recommend an **extended brief intervention**.
- This intervention typically involves **behavior change techniques** and motivational interviewing delivered over several sessions to help the patient reduce consumption.
*Provide simple brief advice about reducing alcohol consumption to lower-risk levels*
- **Simple brief advice** (5-10 minutes) is generally suitable for patients scoring below 8 on the **AUDIT** scale or for low-level opportunistic screening.
- Given his score of 12 and consumption of approx **66 units per week**, a more intensive extended approach is required to be effective.
*Refer to community alcohol services for specialist assessment and intervention*
- Specialized referrals are typically reserved for patients with an **AUDIT score ≥20** or those showing signs of physical **alcohol dependence**.
- This patient lacks social or occupational dysfunction and has normal **gamma-GT**, suggesting he does not yet require intensive specialist services.
*Reassure that his drinking is not problematic given normal liver function tests*
- Normal **liver function tests (LFTs)** do not exclude significant health risks such as **hypertension**, various **cancers**, and future liver cirrhosis.
- The patient is drinking nearly five times the recommended **14 units per week** limit, which constitutes a major health risk regardless of current LFT results.
*Prescribe thiamine supplementation and arrange follow-up in 2 weeks*
- **Thiamine (Vitamin B1)** is indicated for those at high risk of **Wernicke-Korsakoff syndrome**, usually seen in **dependent drinkers** or the malnourished.
- This patient is a hazardous drinker but shows no signs of **malnutrition** or alcohol dependence that would necessitate prophylactic thiamine at this stage.
Question 93: A 45-year-old woman with a BMI of 42 kg/m² attends for weight management. She has tried multiple commercial diet programmes without sustained success. Her blood pressure is 146/92 mmHg, HbA1c 43 mmol/mol, and she has grade 2 non-alcoholic fatty liver disease on ultrasound. She is motivated to lose weight and asks about pharmacological options. According to NICE guidance, which medication would be the most appropriate first-line pharmacological intervention?
A. Orlistat 120mg three times daily with meals (Correct Answer)
B. Liraglutide 3mg subcutaneous injection daily
C. Naltrexone-bupropion combination therapy
D. Semaglutide 2.4mg subcutaneous injection weekly
E. Phentermine 37.5mg daily
Explanation: ***Orlistat 120mg three times daily with meals***
- According to **NICE guidelines (NG49)**, **Orlistat** is the first-line pharmacological treatment for obesity in patients with a BMI
≥30 kg/m² or ≥28 kg/m² with risk factors (hypertension and NAFLD in this patient).
- It functions by inhibiting **gastric and pancreatic lipases**, thereby reducing the absorption of dietary fat by approximately 30%.
*Liraglutide 3mg subcutaneous injection daily*
- While licensed for weight management, NICE typically restricts its use to **specialist weight management services** for patients with a BMI ≥35 kg/m² and specific comorbidities.
- It is generally considered following a trial of lifestyle interventions and is not the primary first-line choice over **Orlistat** in standard primary care settings.
*Naltrexone-bupropion combination therapy*
- This combination therapy is **not currently recommended** by NICE for routine use in the management of obesity within the NHS.
- Its use is limited by concerns regarding **cost-effectiveness** and its clinical place compared to other established treatments.
*Semaglutide 2.4mg subcutaneous injection weekly*
- While highly effective, NICE guidance specifies its use within **specialist weight management services** for patients with at least one weight-related comorbidity.
- It is not positioned as the initial first-line pharmacological intervention in a general primary care weight management pathway.
*Phentermine 37.5mg daily*
- This medication is **not licensed** for use in the UK for the management of obesity due to concerns over its safety profile and potential for misuse.
- Centrally acting stimulants like phentermine have been largely replaced by treatments with more favorable **benefit-risk ratios**.
Question 94: A 28-year-old woman who is 28 weeks pregnant attends for routine antenatal care. Her midwife has documented that her oral glucose tolerance test (OGTT) shows a fasting glucose of 5.8 mmol/L and 2-hour glucose of 8.2 mmol/L. She has a BMI of 34 kg/m², and her father has type 2 diabetes. She feels well with no polyuria or polydipsia. What is the most appropriate immediate management of these results?
A. Diagnose gestational diabetes and refer to joint diabetic-antenatal clinic within 1 week (Correct Answer)
B. Reassure that results are normal for pregnancy and continue routine antenatal care
C. Start metformin 500mg twice daily and review in 2 weeks
D. Advise dietary modification and arrange repeat OGTT in 4 weeks
E. Check HbA1c to confirm the diagnosis before starting treatment
Explanation: ***Diagnose gestational diabetes and refer to joint diabetic-antenatal clinic within 1 week***
- According to **NICE guidelines**, gestational diabetes is diagnosed if the **fasting glucose** is ≥5.6 mmol/L or the **2-hour glucose** is ≥7.8 mmol/L. This patient's values (5.8 and 8.2 mmol/L) meet both criteria.
- **Prompt referral** to a joint diabetic-antenatal clinic is crucial for structured education, dietary advice, glucose monitoring, and potential medical management to optimize maternal and fetal outcomes.
*Reassure that results are normal for pregnancy and continue routine antenatal care*
- These results are clearly **abnormal** and exceed the diagnostic thresholds for **gestational diabetes mellitus (GDM)**. Reassurance would be inappropriate and dangerous.
- Failing to diagnose and manage GDM significantly increases risks of **macrosomia**, **pre-eclampsia**, **polyhydramnios**, and **neonatal hypoglycemia**.
*Start metformin 500mg twice daily and review in 2 weeks*
- Immediate pharmacological intervention is generally not the first line. Initial management involves a trial of **dietary and lifestyle modifications** under specialist guidance.
- Medication such as metformin is typically considered if lifestyle changes are insufficient, following **specialist review** and a period of blood glucose monitoring.
*Advise dietary modification and arrange repeat OGTT in 4 weeks*
- A repeat OGTT is **unnecessary** as the diagnosis of GDM has already been confirmed by the initial abnormal test results.
- While dietary modification is part of management, delaying a comprehensive clinical review for 4 weeks is not appropriate and could lead to uncontrolled hyperglycemia impacting fetal development.
*Check HbA1c to confirm the diagnosis before starting treatment*
- **HbA1c is not recommended** for diagnosing GDM because it lacks sensitivity in pregnancy and reflects average glucose levels over the preceding 2-3 months, not the acute changes of pregnancy.
- The **OGTT** is the established gold standard for diagnosing GDM, and further confirmatory testing with HbA1c is not required.
Question 95: A 67-year-old woman attends following her NHS abdominal aortic aneurysm (AAA) screening ultrasound which detected a 4.8 cm infrarenal AAA. She is asymptomatic. She has well-controlled hypertension on ramipril 10mg daily, blood pressure 128/76 mmHg. She stopped smoking 5 years ago (30 pack-year history). She asks about her prognosis and management options. What is the most appropriate management plan?
A. Arrange ultrasound surveillance every 12 months
B. Arrange ultrasound surveillance every 3 months
C. Refer for elective surgical repair within 8 weeks
D. Arrange CT angiography and refer to vascular surgery for consideration of repair (Correct Answer)
E. Arrange urgent surgical repair within 2 weeks
Explanation: ***Arrange CT angiography and refer to vascular surgery for consideration of repair***
- For an **Abdominal Aortic Aneurysm (AAA)** measuring **4.5 - 5.4 cm**, current guidelines recommend referral to a **vascular surgeon** for detailed assessment and consideration of repair.
- **CT angiography** is the next diagnostic step to evaluate the anatomy and determine suitability for either **Endovascular Aneurysm Repair (EVAR)** or open surgical repair.
*Arrange ultrasound surveillance every 12 months*
- **Annual ultrasound surveillance** is typically reserved for small aneurysms measuring **3.0 - 4.4 cm**.
- Since this patient's AAA is **4.8 cm**, yearly monitoring is insufficient as the risk of rupture increases significantly above 4.5 cm.
*Arrange ultrasound surveillance every 3 months*
- **3-monthly surveillance** is generally indicated when the aneurysm reaches **5.0 - 5.4 cm** or if there is documented rapid expansion.
- This frequency is used to monitor patients closely before they reach the **5.5 cm threshold** where elective surgery is routinely offered.
*Refer for elective surgical repair within 8 weeks*
- Immediate booking for elective repair is usually indicated once the AAA reaches **≥ 5.5 cm** in diameter.
- At **4.8 cm**, the patient requires specialist **vascular assessment** and imaging first to weigh the risks of surgery against the risk of rupture.
*Arrange urgent surgical repair within 2 weeks*
- **Urgent repair** within 2 weeks is indicated for **symptomatic** aneurysms (e.g., pain/tenderness) or those showing **rapid expansion** (>1 cm per year).
- This patient is **asymptomatic** and her aneurysm size does not meet the criteria for emergency or urgent surgical intervention.
Question 96: A 66-year-old man attends for cardiovascular risk assessment. He has a 10-year QRISK3 score of 12%. He smokes 15 cigarettes daily, has a BMI of 31 kg/m², blood pressure 138/86 mmHg, total cholesterol 5.8 mmol/L, HDL 1.1 mmol/L, and HbA1c 41 mmol/mol. He is reluctant to take medication. Using motivational interviewing techniques, which approach is most likely to effectively support behaviour change?
A. Explain the serious health consequences of smoking and obesity in detail to increase his concern
B. Prescribe atorvastatin and arrange smoking cessation support, emphasising the importance of compliance
C. Explore his own reasons for wanting to be healthy and support him to identify his priority for change (Correct Answer)
D. Advise him that his cardiovascular risk is significant and he should stop smoking and lose weight immediately
E. Provide written information about lifestyle modification and arrange review in 6 months
Explanation: ***Explore his own reasons for wanting to be healthy and support him to identify his priority for change***
- This approach is central to **motivational interviewing**, focusing on **eliciting intrinsic motivation** by understanding the patient's values and goals.
- By empowering the patient to identify their own priorities for change, it fosters **autonomy** and commitment, which are key for sustainable **behavior change**.
*Explain the serious health consequences of smoking and obesity in detail to increase his concern*
- While well-intentioned, this **directive** approach can lead to **resistance** or defensiveness, as it may feel like lecturing rather than collaboration.
- **Fear-based tactics** are generally less effective in motivational interviewing than exploring the patient's existing **ambivalence** and readiness to change.
*Prescribe atorvastatin and arrange smoking cessation support, emphasising the importance of compliance*
- This approach disregards the patient's stated **reluctance to take medication** and is overly prescriptive, undermining the patient's **autonomy**.
- Emphasizing compliance without addressing the patient's underlying motivation and barriers often leads to poor adherence and a damaged **therapeutic relationship**.
*Advise him that his cardiovascular risk is significant and he should stop smoking and lose weight immediately*
- Direct advice, especially when framed as an immediate command, can trigger **psychological reactance** and strengthen the patient's resistance to change.
- This approach lacks the **empathy** and collaborative spirit fundamental to motivational interviewing, which aims to work *with* the patient.
*Provide written information about lifestyle modification and arrange review in 6 months*
- This is a largely **passive** intervention that fails to actively engage the patient in a discussion about their motivations and barriers to change.
- While information is important, it is rarely sufficient on its own to drive significant and lasting **behavior change**, especially for complex lifestyle issues.
Question 97: A 30-year-old woman attends for cervical screening. Her hrHPV test is positive, and cytology shows low-grade dyskaryosis. Colposcopy performed 8 weeks later shows acetowhite changes in the transformation zone, and punch biopsies confirm CIN1. She has no symptoms and examination is otherwise normal. She is in a stable relationship and uses the combined oral contraceptive pill. What is the most appropriate management plan?
A. Discharge back to routine 3-yearly cervical screening
B. Arrange repeat colposcopy in 12 months with hrHPV test (Correct Answer)
C. Arrange cold coagulation treatment of the transformation zone
D. Arrange large loop excision of transformation zone (LLETZ) treatment
E. Arrange repeat hrHPV test and cytology in 12 months
Explanation: ***Arrange repeat colposcopy in 12 months with hrHPV test***
- **CIN1** represents **mild dysplasia** and has a high rate of **spontaneous regression**, so conservative management is favored over immediate intervention.
- Following a punch biopsy confirming CIN1, current guidelines recommend **cervical surveillance** at 12 months to monitor for persistence or resolution, which includes repeat colposcopy and hrHPV testing.
*Discharge back to routine 3-yearly cervical screening*
- Routine screening is only appropriate once the patient has tested **hrHPV negative** at a surveillance check.
- Discharging the patient now would be unsafe as the presence of **hrHPV and CIN1** requires closer monitoring than the general population.
*Arrange cold coagulation treatment of the transformation zone*
- **Cold coagulation** is an ablative treatment that is generally unnecessary for biopsy-proven **CIN1**, which often resolves without surgery.
- Use of ablative or excisional treatments for low-grade lesions leads to **overtreatment** and potential complications like cervical scarring.
*Arrange large loop excision of transformation zone (LLETZ) treatment*
- **LLETZ** is usually reserved for **high-grade lesions (CIN2 or CIN3)** or persistent CIN1 that has not resolved over a period of two years.
- Immediate LLETZ for CIN1 carries unnecessary risks for **future pregnancy**, such as increased risk of **preterm labor** or cervical incompetence.
*Arrange repeat hrHPV test and cytology in 12 months*
- While a 12-month follow-up is correct, patients with histologically confirmed CIN1 remaining under colposcopic care necessitate an **integrated assessment** including colposcopy.
- Simply performing primary care cytology would be insufficient for a patient who has already entered the **colposcopy pathway** with a proven histological lesion.
Question 98: A 63-year-old man attends for discussion of his NHS bowel cancer screening result. His faecal immunochemical test (FIT) shows a result of 85 micrograms of haemoglobin per gram of faeces. He is asymptomatic with no change in bowel habit, no rectal bleeding, and no weight loss. Abdominal examination is unremarkable. He takes aspirin 75mg daily for secondary prevention following a previous myocardial infarction. What is the most appropriate management?
A. Refer for colonoscopy via the bowel cancer screening programme (Correct Answer)
B. Arrange routine 2-week-wait referral to colorectal surgery
C. Repeat FIT in 2 years as part of routine screening
D. Stop aspirin for 2 weeks and repeat FIT
E. Repeat FIT in 3 months to confirm the result
Explanation: ***Refer for colonoscopy via the bowel cancer screening programme***- For the **NHS Bowel Cancer Screening Programme**, a **FIT result of 85μg/g** is significantly above the threshold (typically ≥10μg/g) that warrants further investigation with colonoscopy.- Since this positive result was obtained through the formal **screening pathway** in an asymptomatic patient, referral should be managed directly by the dedicated **bowel cancer screening programme** for appropriate follow-up.
*Arrange routine 2-week-wait referral to colorectal surgery*- The **2-week-wait (2WW) referral pathway** is primarily for **symptomatic patients** presenting to their GP with concerning features, or for GP-requested FITs.- Positive screening results are managed by the specialized **Bowel Cancer Screening Centres**, which have their own system for arranging prompt colonoscopies.
*Repeat FIT in 2 years as part of routine screening*- A **FIT result of 85μg/g** is a positive finding indicating significant occult blood loss, requiring urgent investigation, not routine deferral.- Routine biennial screening is only appropriate for individuals with a **negative FIT result**; delaying investigation of a positive result could miss early cancer.
*Stop aspirin for 2 weeks and repeat FIT*- Modern **Faecal Immunochemical Tests (FIT)** specifically detect **human haemoglobin** and are generally not affected by medications like low-dose **aspirin**.- Stopping **aspirin** for secondary prevention of a myocardial infarction is associated with **increased cardiovascular risk** and is not indicated for FIT accuracy.
*Repeat FIT in 3 months to confirm the result*- A single **positive FIT result** at the screening threshold is sufficient to trigger a referral for colonoscopy; there is no protocol to
Question 99: A 51-year-old woman with type 2 diabetes attends for her annual diabetic retinopathy screening. The report indicates 'R2 - referable retinopathy with venous beading and multiple deep retinal haemorrhages in all four quadrants, but no neovascularisation'. Visual acuity is 6/9 in both eyes. She reports no visual symptoms. Her HbA1c is 76 mmol/mol and blood pressure is 142/88 mmHg. What is the most appropriate action regarding her retinopathy?
A. Refer urgently to ophthalmology for review within 2 weeks
B. Arrange immediate same-day referral to ophthalmology
C. Refer to ophthalmology for review within 6 weeks
D. Refer routinely to ophthalmology for review within 13 weeks (Correct Answer)
E. Intensify glycaemic and blood pressure control and repeat screening in 6 months
Explanation: ***Refer routinely to ophthalmology for review within 13 weeks***
- The clinical description of **venous beading** and **multiple deep retinal haemorrhages** in all four quadrants, without neovascularisation, defines **severe non-proliferative diabetic retinopathy (R2)**.
- According to the **NHS Diabetic Eye Screening Programme (DESP) guidelines**, **R2 retinopathy** without active proliferation requires a routine referral to ophthalmology within **13 weeks**.
*Refer urgently to ophthalmology for review within 2 weeks*
- This timeframe is for **proliferative diabetic retinopathy (R3)**, which is characterized by the presence of **neovascularization**, or clinically significant macular edema (M1).
- The patient's report explicitly states **no neovascularization**, making an urgent 2-week referral unsuitable for R2 retinopathy.
*Arrange immediate same-day referral to ophthalmology*
- An immediate referral is reserved for acute, sight-threatening emergencies such as a **vitreous haemorrhage**, **retinal detachment**, or sudden, severe **vision loss**.
- The patient is **asymptomatic** with stable visual acuity (6/9), indicating no immediate sight-threatening emergency.
*Refer to ophthalmology for review within 6 weeks*
- A **6-week referral** category is not a recognized or standard timeframe within the **UK national diabetic eye screening referral protocols**.
- Adhering to established guidelines (13 weeks for R2) ensures appropriate and timely management based on validated risk stratification.
*Intensify glycaemic and blood pressure control and repeat screening in 6 months*
- While optimizing **HbA1c** and **blood pressure** is vital for overall diabetes management and slowing retinopathy progression, it does not replace the immediate need for specialist ophthalmology review for **referable R2 retinopathy**.
- Delaying a specialist referral by merely repeating screening in **6 months** for established severe non-proliferative changes would be inappropriate and could lead to progression or complications.
Question 100: A 64-year-old woman attends for results of her NHS breast screening mammogram. The report states 'M3 - indeterminate/probably benign calcifications detected in the upper outer quadrant of the right breast'. She is asymptomatic and has no palpable abnormality on clinical examination. Her mother had breast cancer diagnosed at age 72. What is the most appropriate next step in her management?
A. Reassure and arrange routine repeat mammography in 3 years
B. Refer to breast clinic for triple assessment within 2 weeks (Correct Answer)
C. Arrange MRI breast imaging to further characterise the lesion
D. Arrange repeat mammography in 6 months
E. Arrange ultrasound-guided core biopsy within 1 week
Explanation: ***Refer to breast clinic for triple assessment within 2 weeks***
- An **M3 mammographic classification** denotes an indeterminate or probably benign finding that requires urgent evaluation to rule out malignancy.
- The standard of care for any suspicious screening result is a **triple assessment**, comprising clinical examination, further imaging (magnification views/ultrasound), and potentially a biopsy.
*Reassure and arrange routine repeat mammography in 3 years*
- Routine 3-yearly screening is only appropriate for **M1 (normal)** or **M2 (benign)** results where no further action is required.
- Delaying assessment for an **M3 lesion** carries a significant risk of missing an early-stage cancer.
*Arrange MRI breast imaging to further characterise the lesion*
- **MRI** is not the first-line investigation for indeterminate calcifications and is usually reserved for specific indications like dense breast tissue or high-risk screening.
- Imaging decisions should be made by the specialist team as part of the formal **triple assessment** process.
*Arrange repeat mammography in 6 months*
- Short-interval follow-up is generally not recommended for **M3 lesions** identified in a screening program; they require immediate definitive assessment.
- Managing indeterminate findings through monitoring alone without initial **triple assessment** is unsafe clinical practice.
*Arrange ultrasound-guided core biopsy within 1 week*
- While a biopsy might be necessary, it should be performed after specialist clinical review and further **mammographic focal/magnification views**.
- Specifically for calcifications, a **stereotactic vacuum-assisted biopsy** is often more appropriate than a standard ultrasound-guided core biopsy.
